Back to results
US 2022/0009913 A1Published application
Small molecule inhibitors of galectin-3
AssigneeBristol-Myers Squibb Company
InventorsJacob Swidorski, Brett R. Beno, David S. Yoon, Alicia Regueiro-Ren
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds of formula I, which inhibit Gal-3, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions.
Claims13
A compound of formula I
- where:
- R1 is ((R3)(R4)N)carbonyl or Ar2;
- R2 is —O-L1-O—, —OCON(R5)-L2-N(R5)C(O)O—, or —O-(L3)-CON(R5)-L2-N(R5)C(O)-(L3)-O—;
- L1 is alkylene;
- L2 is alkylene, or —CH2-Ph-CH2—;
- or N(R5)-L2-N(R5) taken together is piperazinyl, or homopiperazinyl;
- L3 is alkylene;
- R3 is hydrogen, alkyl, cycloalkyl, benzyl, or halobenzyl;
- R4 is hydrogen or alkyl;
- or (R3)(R4)N taken together is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholinyl, and is substituted with 0-3 substituents selected from halo, alkyl, and alkylcarbonyl;
- R5 is hydrogen or alkyl;
- R6 is hydrogen or alkyl;
- R7 is hydrogen or alkyl;
- or (R6)(R7)N taken together is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholinyl, and is substituted with 0-3 substituents selected from halo, alkyl, and hydroxy;
- R8 is hydrogen, alkyl, alkylcarbonyl, or alkylsulfonyl;
- R9 is hydrogen or alkyl;
- or (R8)(R9)N taken together is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholinyl, and is substituted with 0-3 substituents selected from halo, alkyl, and alkylcarbonyl;
- R10 is cyano, halo, alkoxy, or (R11)(R12)N;
- R11 is hydrogen or alkyl;
- R12 is hydrogen or alkyl;
- or (R11)(R12)N taken together is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholinyl;
- R13 is hydrogen, alkyl, alkylcarbonyl, alkoxycarbonyl, or alkylsulfonyl;
- R14 is hydrogen or alkyl;
- or (R13)(R14)N taken together is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholinyl, and is substituted with 0-3 substituents selected from halo, alkyl, and hydroxy;
- R15 is hydrogen, alkyl, alkylcarbonyl, or alkylsulfonyl;
- R16 is hydrogen or alkyl;
- or (R15)(R16)N taken together is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholinyl, and is substituted with 0-3 substituents selected from halo, alkyl, and alkylcarbonyl;
- Ar1 is pyrrolyl, furanyl, thienyl, pyrazolyl, isoxazolyl, isothiazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, phenyl, or indolyl, and is substituted with 0-3 substituents selected from alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, (carboxy)alkyl, (alkoxycarbonyl)alkyl, (H2NCO)alkyl, (Ar3)alkyl, cycloalkyl, hydroxycycloalkyl, alkenyl, alkoxy, alkylthio, alkylsulfonyl, carboxy, alkoxycarbonyl, (alkylNH)carbonyl, (((R6)(R7)N)alkylNH)carbonyl, ((pyridinyl)alkylNH)carbonyl, (R8)(R9)N, and Ar3;
- Ar2 is phenyl, pyridinyl, naphthyl, benzoxazolyl, benzothiazolyl, quinolinyl, or quinoxalinyl, and is substituted with 0-5 substituents selected from cyano, halo, alkyl, (R10)alkyl, haloalkyl, cycloalkyl, (R10)cycloalkyl, alkoxy, cycloalkoxy, haloalkoxy, and (R13)(R14)N;
- and
- Ar3 is phenyl, naphthalinyl, biphenyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, quinolinyl, isoquinolinyl, quinoxainyl, indolyl, indazolyl, benzimidazolyl, benzisoxazolyl, benzisothiazolyl, benzoxazolyl, benzothiazolyl, benzodioxolyl, dihydrobenzodioxinyl, dihydroquinolinonyl, or dihydrobenzothiophene-2,2-dioxide, and is substituted with 0-5 substituents selected from cyano, nitro, halo, alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkylthio, carboxy, alkoxycarbonyl, CONH2, and (R15)(R16)N;
- or Ar3 is pyrrolyl, furanyl, thienyl, pyrazolyl, isoxazolyl, isothiazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, or thiadiazolyl, and is substituted with 0-3 substituents selected from cyano, nitro, halo, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, carboxy, alkoxycarbonyl, CONH2, and (R15)(R16)N;
- or Ar3 is (alkylSO2)phenyl, (alkylSO2)(halo)phenyl, (aminoSO2)phenyl, (dialkylaminoSO2)phenyl, ((alkylNHSO2)alkyl)phenyl, (pyrrolyl)phenyl, (imidazolyl)phenyl, (oxazolyl)phenyl, (tetrazolyl)phenyl, ((pyridinyl)methyl)phenyl, phenoxyphenyl, (benzyloxy)phenyl, ((methyl)thiazolyl)phenyl, (thiazolyl)benzenesulfamido, ((methyl)thiadiazolyl)benzenesulfamido, (methyl)benzothiazolonyl, or fluoropyrazolopyrimidinyl;
- or a pharmaceutically acceptable salt thereof.
31 more elements
(canceled)
Dependencies are inferred from the claim text.